The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality
Abstract Background Impaired T cell immune function exists in end-stage renal disease (ESRD) patients. Dialysis treatment may lead to changes in T cell subsets. In the present study, we aimed to identify alterations of T cell phenotypes in ESRD patients, especially in those receiving peritoneal dial...
Main Authors: | Jiao Xiaoyan, Chen Rongyi, Cao Xuesen, Zou Jianzhou, Ji Jun, Ding Xiaoqiang, Yu Xiaofang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-019-1475-y |
Similar Items
-
Economic Burden and Medical Insurance Impact of the Different Dialysis for End-stage Renal Diseases
by: Dan GAO, et al.
Published: (2018-11-01) -
Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005–2012 Study
by: Po-Cheng Su, et al.
Published: (2022-10-01) -
Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model
by: Septiara Putri, et al.
Published: (2022-12-01) -
Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients
by: Jarcy Zee, et al.
Published: (2018-10-01) -
Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study
by: Zhiren He, et al.
Published: (2020-09-01)